scholarly article | Q13442814 |
P356 | DOI | 10.1093/HMG/8.12.2311 |
P698 | PubMed publication ID | 10545612 |
P50 | author | Susan A. Berry | Q37838250 |
P2093 | author name string | G Zhou | |
B Lee | |||
D Chitayat | |||
Y Chen | |||
L Zhou | |||
S Pirinen | |||
C R Greenberg | |||
B D Gelb | |||
G Karsenty | |||
J Hecht | |||
K Thirunavukkarasu | |||
P433 | issue | 12 | |
P921 | main subject | cleidocranial dysplasia | Q781618 |
P304 | page(s) | 2311-2316 | |
P577 | publication date | 1999-11-01 | |
P1433 | published in | Human Molecular Genetics | Q2720965 |
P1476 | title | CBFA1 mutation analysis and functional correlation with phenotypic variability in cleidocranial dysplasia | |
P478 | volume | 8 |
Q37090039 | A Runx2 threshold for the cleidocranial dysplasia phenotype |
Q50489481 | A natural history of cleidocranial dysplasia. |
Q33312873 | A novel RUNX2 missense mutation predicted to disrupt DNA binding causes cleidocranial dysplasia in a large Chinese family with hyperplastic nails |
Q45276711 | A novel in-frame deletion of the RUNX2 gene causes a classic form of cleidocranial dysplasia |
Q33802810 | A novel small deletion mutation in RUNX2 gene in one Chinese family with cleidocranial dysplasia |
Q40489175 | Analysis of novel RUNX2 mutations in Chinese patients with cleidocranial dysplasia. |
Q28314719 | Atypical expression of cleidocranial dysplasia: clinical and molecular-genetic analysis |
Q48230925 | Calvarial bone development and suture closure in Dicer-deficient mice |
Q28509530 | Causal relationship between the loss of RUNX3 expression and gastric cancer |
Q28586662 | Cbfbeta interacts with Runx2 and has a critical role in bone development |
Q34021053 | Characterization of a new syndrome that associates craniosynostosis, delayed fontanel closure, parietal foramina, imperforate anus, and skin eruption: CDAGS. |
Q58008676 | Chloride binding by the AML1/Runx1 transcription factor studied by NMR |
Q34159998 | Cleidocranial dysplasia |
Q45931410 | Cleidocranial dysplasia syndrome (CCD) with an unusual finding in a young patient. |
Q42880373 | Cleidocranial dysplasia syndrome: clinical characteristics and mutation study of a Chinese family |
Q36321287 | Cleidocranial dysplasia: a rare cause of disproportionate severe short stature |
Q77067494 | Common mutations and independent assortment of CCD |
Q84083677 | Common polymorphisms rather than rare genetic variants of the Runx2 gene are associated with femoral neck BMD in Spanish women |
Q35686477 | Cone-beam computed tomography: An inevitable investigation in cleidocranial dysplasia |
Q53252888 | Core binding factor β of osteoblasts maintains cortical bone mass via stabilization of Runx2 in mice. |
Q42840092 | Correlation between genotype and supernumerary tooth formation in cleidocranial dysplasia |
Q27639779 | DNA recognition by the RUNX1 transcription factor is mediated by an allosteric transition in the RUNT domain and by DNA bending |
Q51966876 | De novo three-way chromosome translocation 46,XY,t(4;6;21)(p16;p21.1;q21) in a male with cleidocranial dysplasia. |
Q30443541 | Disease mutations in RUNX1 and RUNX2 create nonfunctional, dominant-negative, or hypomorphic alleles. |
Q35539737 | Dominance of SOX9 function over RUNX2 during skeletogenesis |
Q34015442 | Dysregulation of chondrogenesis in human cleidocranial dysplasia |
Q35737205 | Ectopic expression of SOX9 in osteoblasts alters bone mechanical properties. |
Q44478788 | Energetic contribution of residues in the Runx1 Runt domain to DNA binding. |
Q24292735 | Evidence for haploinsufficiency of the human HNF1alpha gene revealed by functional characterization of MODY3-associated mutations |
Q37202869 | Functional analysis of RUNX2 mutations in Japanese patients with cleidocranial dysplasia demonstrates novel genotype-phenotype correlations |
Q53862836 | Functional analysis of RUNX2 mutations in cleidocranial dysplasia: novel insights into genotype–phenotype correlations |
Q46770314 | Functional analysis of a novel RUNX2 missense mutation found in a family with cleidocranial dysplasia |
Q36558882 | Generation of cleidocranial dysplasia-specific human induced pluripotent stem cells in completely serum-, feeder-, and integration-free culture |
Q36291161 | Identification and characterization of the novel Col10a1 regulatory mechanism during chondrocyte hypertrophic differentiation |
Q90244304 | Identification of RUNX2 variants associated with cleidocranial dysplasia |
Q33341337 | Identification of a new pebp2alphaA2 isoform from zebrafish runx2 capable of inducing osteocalcin gene expression in vitro. |
Q104576050 | Identification of a novel RUNX2 gene mutation and early diagnosis of CCD in a cleidocranial dysplasia suspected Iranian family |
Q77425768 | Identification of novel CBFA1/RUNX2 mutations causing cleidocranial dysplasia |
Q36843000 | Intragenic microdeletion of RUNX2 is a novel mechanism for cleidocranial dysplasia |
Q37195995 | Localization of the cis-enhancer element for mouse type X collagen expression in hypertrophic chondrocytes in vivo. |
Q34147546 | Loss of jab1 in osteochondral progenitor cells severely impairs embryonic limb development in mice |
Q42689082 | MESENCHYMAL STROMAL CELLS AND THEIR ORTHOPAEDIC APPLICATIONS. |
Q35652284 | Mitotic retention of gene expression patterns by the cell fate-determining transcription factor Runx2. |
Q35283051 | Molecular genetics of supernumerary tooth formation |
Q47248157 | Mutant Runx2 regulates amelogenesis and osteogenesis through a miR-185-5p-Dlx2 axis |
Q28202887 | Mutations in the RUNX2 gene in patients with cleidocranial dysplasia |
Q48296544 | New mutations in the CBFA1 gene in two Mexican patients with cleidocranial dysplasia |
Q47708056 | Novel Mutation of the RUNX2 Gene in Patients with Cleidocranial Dysplasia. |
Q41980849 | Osteoclastogenic potential of peripheral blood mononuclear cells in cleidocranial dysplasia |
Q35779731 | Point mutations in the RUNX1/AML1 gene: another actor in RUNX leukemia |
Q37592911 | Post-translational Regulation of Runx2 in Bone and Cartilage |
Q37325296 | RUNX2 mutations in Chinese patients with cleidocranial dysplasia. |
Q28334414 | RUNX2 tandem repeats and the evolution of facial length in placental mammals |
Q37720402 | RUNX3 is multifunctional in carcinogenesis of multiple solid tumors |
Q35569321 | Runx2 contributes to murine Col10a1 gene regulation through direct interaction with its cis-enhancer |
Q36635990 | Runx2 protein represses Axin2 expression in osteoblasts and is required for craniosynostosis in Axin2-deficient mice |
Q59796207 | Schädelanomalien bei Dysostosis cleidocranialis |
Q34333682 | Selective Runx2-II deficiency leads to low-turnover osteopenia in adult mice |
Q35121727 | Structural and functional characterization of Runx1, CBF beta, and CBF beta-SMMHC. |
Q22254263 | Structural basis for the heterodimeric interaction between the acute leukaemia-associated transcription factors AML1 and CBFbeta |
Q51736628 | Surgical Management and Evaluation of the Craniofacial Growth and Morphology in Cleidocranial Dysplasia. |
Q44728270 | TEL-AML1 preleukemic activity requires the DNA binding domain of AML1 and the dimerization and corepressor binding domains of TEL. |
Q24306231 | The RUNX1 Runt domain at 1.25A resolution: a structural switch and specifically bound chloride ions modulate DNA binding |
Q35068916 | The cleidocranial dysplasia-related R131G mutation in the Runt-related transcription factor RUNX2 disrupts binding to DNA but not CBF-beta |
Q28590530 | The core-binding factor beta subunit is required for bone formation and hematopoietic maturation |
Q42463915 | The role of periodontal ligament cells in delayed tooth eruption in patients with cleidocranial dysostosis |
Q34448188 | The role of the AML1 transcription factor in leukemogenesis |
Q36702566 | The transcriptional co-regulator Jab1 is crucial for chondrocyte differentiation in vivo |
Q33732988 | Transcriptional corepressor TLE1 functions with Runx2 in epigenetic repression of ribosomal RNA genes |
Q28578731 | Transforming growth factor-beta3 (Tgf-beta3) down-regulates Tgf-beta3 receptor type I (Tbetar-I) during rescue of cranial sutures from osseous obliteration |
Q36323301 | Type X collagen gene regulation by Runx2 contributes directly to its hypertrophic chondrocyte-specific expression in vivo |
Q37262646 | Uncoupling of chondrocyte differentiation and perichondrial mineralization underlies the skeletal dysplasia in tricho-rhino-phalangeal syndrome. |
Q35779139 | Use of Targeted Exome Sequencing for Molecular Diagnosis of Skeletal Disorders |
Q37479281 | Williams-Beuren syndrome-associated transcription factor TFII-I regulates osteogenic marker genes |
Q54575578 | [Cleidocranial dysplasia. Description and analysis of a patient cohort]. |
Q36631181 | p204 protein overcomes the inhibition of core binding factor alpha-1-mediated osteogenic differentiation by Id helix-loop-helix proteins. |
Search more.